Real-time enrollment status for this glioma, malignant clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:13 AM UTC
| NCT Number | NCT05226494 |
| Recruiting Status | Recruiting |
| Condition | Glioma, Malignant |
| Phase | PHASE1 |
| Target Enrollment | 34 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NanoPharmaceuticals LLC |
| Last Updated on CT.gov | June 4, 2025 (Jun 4, 2025) |
As of July 17, 2026: Clinical trial NCT05226494 is currently recruiting participants. This phase1 study for glioma, malignant is actively seeking new participants at 1 location across the United States. The study is sponsored by NanoPharmaceuticals LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05226494 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05226494 was last updated Jun 4, 2025 (June 4, 2025). HelloStudys verifies this status automatically.